Stereo-seq Spatial Data Challenge Now Open
Whether you're a seasoned data maverick or a curious newcomer, this challenge is your ticket to experiencing the power of spatial data analysis. The Challenge is LIVE NOW and remains open until 30th November 2023. During this period you can participate at your pace. Depending on your familiarity with Conda and Jupyter, you may need 3 to 6 hours in total to complete all the tasks. Embrace this chance to make your mark in spatial transcriptomics, and win epic prizes such as STOmics Cloud subscriptions valued up to $9,500, Fitbit Smart Watches, ergonomic wireless keyboard & mouse sets, and STOmics Rubik's Cubes, to keep your mind and boy fit! Seize this opportunity to wield the power of Stereo-seq, the most accessible spatial platform brought to you by MGI and STOmics.
Registration is open. Sign up now and secure your spot!🧬🏆⏰
Brisbane, 20 October 2022 – BGI Australia’s lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing in Australia. The state-of-the-art facility has been empowering Australian scientists in their innovative research since 2017 and is now providing clinical services for the wider community. The NATA accreditation adopts the internationally-recognised ISO15189 and meets the accreditation standards for pathology laboratories set by the National Pathology Accreditation Advisory Council. Dr. Bicheng Yang, Director of BGI Australia said “We will continue to improve and increase the accessibility of clinical sequencing to clinical laboratories, research institutes and hospitals.”
BGI Rapid Antigen Test is available now
BGI announces that its 2019-nCoV Ag Test has recently been included in the Australian Register of Therapeutic Goods (ARTG).
The test kit is designed for detecting SARS CoV-2 nucleocapsid protein antigen for individuals suspected to have contracted COVID-19.
What's New
COVID-19 Updates
Promotions & Grants
COVID-19 Updates
BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.
News
Promotions & Grants
COVID-19 Updates
Check in on the latest news at BGI Australia.
- BGI partners with Minderoo to launch Huo-Yan Laboratory Solution to expedite Australia-wide COVID-19 testing.
Promotions & Grants
Promotions & Grants
Promotions & Grants
Keep an eye out here for our promotions and grants. Be notified when applications open.
Explore
Core Capability
Core Capability
Core Capability
Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources,
Research
Core Capability
Core Capability
BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.
Instruments
Core Capability
Instruments
Check out our latest range of MGI sequencing platforms and diagnostic devices.
Services
Customer Testimonials
Instruments
We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.
Partners
Customer Testimonials
Customer Testimonials
We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.
Customer Testimonials
Customer Testimonials
Customer Testimonials
We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.
